Imerys SA

Imerys SA

21.48
EUR
-0.46
(-2.10%)
2.37BMarket Cap
Feb 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
48.94
48.44
51.55
52.91
54.41
57.93
55.06
46.23
43.27
50.62
44.87
42.62
40.01
- -
Basic EPS, GAAP
3.2
3.57
0.86
3.72
4.66
7.06
1.53
0.37
2.84
2.8
0.61
-1.12
-4.83
- -
Free Cash Flow per Basic Share
6.13
5.47
6.87
8.05
3.55
3.45
2.57
3.36
2.14
0.54
2.61
-2.02
1.32
- -
Dividend per Share
1.55
1.61
1.67
1.75
1.88
2.12
2.18
0.21
1.26
1.63
3.86
1.38
1.46
- -
Book Value per Share
29.53
32.29
33.32
36.06
35.81
40.6
39.44
34.23
37.75
39.56
37
38.87
30.82
36.53
Tangible Book Value per Share
14.64
16.79
11.44
13.93
4.9
10.05
8.6
5.48
8.81
14.2
11.27
12.3
10.49
10.41
Basic Weighted Avg Shares
76
76
79
79
79
79
79
82
85
85
85
85
85
85
Sales/Revenue/Turnover
3,698
3,688
4,087
4,165
4,299
4,590
4,355
3,799
3,665
4,282
3,794
3,605
3,384
- -
Operating Margin (%)
11.38
12.08
12.9
13.85
12.04
3.58
8.03
7.83
9.07
9.25
6.65
6.94
5.64
- -
Depreciation Expense
208
209
225
226
266
495
354
343
324
317
511
302
855
- -
Net Income, GAAP
242
272
68
293
368
560
121
30
240
237
51
-95
-409
- -
Effective Tax Rate (%)
29.08
30.13
44.9
32.55
28.25
- -
35.35
57.76
27.23
33.94
87.54
- -
- -
- -
Profit Margin (%)
6.54
7.36
1.67
7.03
8.56
12.19
2.78
0.79
6.55
5.54
1.35
-2.64
-12.08
- -
Working Capital
915
1,251
707
928
486
1,441
868
833
978
1,494
1,185
982
1,246
934
LT Debt
1,190
1,494
1,500
1,602
1,986
1,996
1,884
1,866
1,851
1,793
1,811
1,803
2,141
1,805
Total Equity
2,272
2,471
2,672
2,914
2,878
3,254
3,162
2,961
3,242
3,385
3,157
3,301
2,615
3,109
Return on Invested Capital (%)
7.94
7.93
2.29
6.76
6.62
- -
2.65
1.08
3.99
5.18
0.79
- -
- -
- -
Return on Capital (%)
7.83
7.94
2.32
6.97
7.66
- -
2.91
0.9
4.94
4.47
0.97
- -
- -
- -
Return on Common Equity (%)
10.79
11.58
2.69
10.64
12.94
18.52
3.83
1
7.88
7.26
1.59
-2.97
-13.9
- -

Capital Structure

EUR

•

in mil. unless spec.
Sep'24
Dec'24
Jun'25
ST Debt
- -
108
86
LT Borrowings
- -
1,693
1,697
LT Finance Leases
- -
110
108
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
84
84
85
Market Capitalization
2,509
2,374
2,366

Working Capital

EUR

•

in mil. unless spec.
Sep'24
Dec'24
Jun'25
Total Current Assets
- -
1,966
1,816
Cash, Cash Equivalents & STI
- -
640
478
Accounts Receivable, Net
- -
364
403
Inventories
- -
725
706
Total Current Liabilities
- -
984
882
Payables & Accruals
- -
- -
- -
ST Debt
- -
108
86
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.26%
-1.81%
-20.78%
Free Cash Flow
-10.18%
-14.03%
-165.47%
Net Income, GAAP
91.55%
132.64%
330.32%
Sales/Revenue/Turnover
-1.52%
-1.84%
-6.14%
Total Cash Common Dividend
55.12%
122.66%
5.84%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3,605
2025
- -
- -
3,384
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-1.12
2025
- -
- -
-4.83
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.38
2025
- -
- -
1.46
2026
- -
- -
- -

Company Description

CEO
Alessandro Dazza
Full Time Employees
12,445
Sector
Non-energy minerals
Industry
Construction materials
Address
43 Quai de Grenelle Paris IF France 75015
IPO Date
May 5, 2003
Website
imerys.com
Business
Imerys S.A. (NK.PA) produces and processes industrial minerals for specialty applications across diverse sectors including construction, automotive, consumer goods, energy transition, and advanced materials; core products encompass performance minerals such as kaolin, talc, calcium carbonate, and graphite; high-performance solutions for abrasives, advanced ceramics, batteries, fuel cells, and filtration; as well as offerings in refractory materials, thermal insulation, roofing clays, and ImerCare branded minerals for personal care, food, nutrition, pharmaceuticals, and cosmetics. Founded in 1880 and headquartered in Paris, France, the company operates over 230 industrial sites in more than 40 countries spanning the Americas, Europe Middle East Africa, and Asia-Pacific, with North American operations based in Roswell, Georgia. In recent developments, Imerys formed a distribution partnership with LBB Specialties in September 2025 for its ImerCare product line and minerals in personal care, food, and nutrition markets across the United States, Canada, and Puerto Rico; entered a collaboration with Shanghai Shanshan New Material Co. in September 2025 to establish synthetic graphite anode production in Europe via subsidiary Imerys Graphite & Carbon; signed an agreement in October 2025 to acquire SB Mineração in Brazil to bolster its mineral portfolio; implemented a share buyback program in June 2025 authorized by shareholders; announced plans for a major lithium mining operation in Allier, France, commencing in 2027; and previously divested its High Temperature Solutions business to Platinum Equity in 2022 as part of a strategic refocus on high-growth specialty minerals.

Company News

  • Imerys S.A. (IMYSY) Q2 2026 Earnings Call Transcript

  • Imerys S.A. (IMYSY) Shareholder/Analyst Call Transcript

  • Imerys S.A. (IMYSY) Q1 2026 Earnings Call Transcript

  • Amrize (NYSE:AMRZ) versus Imerys (OTCMKTS:IMYSF) Head to Head Contrast

  • Imerys S.A. (IMYSY) Q4 2025 Earnings Call Transcript

  • Imerys freezes UK lithium project to focus on France

  • Financial Analysis: Imerys (OTCMKTS:IMYSF) vs. Wienerberger (OTCMKTS:WBRBY)

  • Imerys (OTCMKTS:IMYSF) Shares Down 3.6% – Here’s What Happened

  • French satellite operator Eutelsat taps Imerys exec as next finance chief

  • Imerys S.A. (IMYSY) Q3 2025 Earnings Call Transcript

  • Imerys S.A. (IMYSF) Q2 2025 Earnings Call Transcript

  • Graphite Miners News For The Month Of June 2025

  • Graphite Miners News For The Month Of May 2025

  • Imerys: Tough Times For Talc

  • Graphite Miners News For The Month Of April 2025

  • Imerys S.A. (IMYSF) Q1 2025 Earnings Call Transcript

  • Imerys S.A. (IMYSF) Q4 2024 Earnings Call Transcript

  • Nucleating & Clarifying Agents Market Outlook 2024-2029, with Profiles for Milliken, Clariant, Adeka, BASF, Avient, Imerys, New Japan Chemical Co, GCH Technology Co, Plastiblends India and More

  • Imerys S.A. (IMYSF) Q3 2024 Earnings Call Transcript

  • Imerys recognizes CynerSorb® as a sustainable solution and Pioneer Product for the Renewable Diesel market